Fuchslocher Chico, J., Falk-Paulsen, M., Luzius, A., Saggau, C., Ruder, B., Bolik, J., . . . Adam, D. (2018). The enhanced susceptibility of ADAM-17 hypomorphic mice to DSS-induced colitis is not ameliorated by loss of RIPK3, revealing an unexpected function of ADAM-17 in necroptosis. Oncotarget.
Stile di citazione ChicagoFuchslocher Chico, Johaiber, et al. "The Enhanced Susceptibility of ADAM-17 Hypomorphic Mice to DSS-induced Colitis Is Not Ameliorated By Loss of RIPK3, Revealing an Unexpected Function of ADAM-17 in Necroptosis." Oncotarget 2018.
Citazione MLAFuchslocher Chico, Johaiber, et al. "The Enhanced Susceptibility of ADAM-17 Hypomorphic Mice to DSS-induced Colitis Is Not Ameliorated By Loss of RIPK3, Revealing an Unexpected Function of ADAM-17 in Necroptosis." Oncotarget 2018.